The 2,2-Difluorocyclobutyl motif in Drug Discovery
Fluorine has earned its place in medicinal chemistry through years of demonstrated utility, but single fluorine substitution and the trifluoromethyl group get most of the attention. Gem-difluorocyclobutyl groups have received considerably less attention despite offering a useful combination of conformational control and physicochemical tuning in appropriate contexts. The 2,2-difluorocyclobutyl group brings together two effects that are individually valuable but particularly powerful in combination. The fluorines reduce the electron density of the ring and alter the conformational preference of substituents at the 1-position through a combination of inductive and stereoelectronic effects. This biases the preferred ring conformation and restricts the conformational space available to adjacent groups, which can improve metabolic stability in suitable scaffolds compared to the corresponding unfluorinated cyclobutyl analogue. The clinical relevance of this effect is well illustrated by ivosidenib, the FDA-approved mutant IDH1 inhibitor, where the gem-difluorocyclobutane motif was found to be crucial in increasing metabolic stability while maintaining potency during lead optimisation. The ring also adds three-dimensional character without a substantial molecular weight penalty. Swapping a flat aromatic substituent for a 2,2-difluorocyclobutyl group reduces planarity, which matters as our understanding of molecular complexity and its relationship to clinical success has evolved. Greater molecular saturation has been associated with improved clinical success in retrospective analyses, and gem-difluorocyclobutyl groups offer alternatives to aromatic rings while introducing distinct steric and electronic properties that can be advantageous during lead optimisation. We have a selection of 2,2-difluorocyclobutyl building blocks in our catalogue, designed for direct use in lead optimisation programmes. Have you incorporated 2,2-difluorocyclobutyl into a lead series? Further reading: 1.Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide‑1 Receptor Agonists with Reduced hERG Inhibitory Activities https://lnkd.in/e4rHPrt8 2. Synthesis of gem-Difluorocyclobutanes: Organolanthanum Enabled Synthesis and Divergent Catalytic Functionalization of gem-Difluorocyclobutanols https://lnkd.in/eK3Ec5\_X 3. Synthesis of gem-Difluorocyclobutane-Fused Indolines via Ruthenium-Catalyzed Defluorinative Annulation of Trifluoromethyl Carbenoids with 2-Alkenylanilines https://lnkd.in/e2pqmCZq
![BICYCLO\[1.1.1\]PENTANES AS PHENYL BIOISOSTERES
There is a tension that runs thr](https://media.licdn.com/dms/image/v2/D4E22AQFnROrlRtpelQ/feedshare-image-high-res/B4EZ.4qUvmJEAY-/0/1785509530849?e=1788393600&v=beta&t=aMcmefcEoFu64vTrYq1kV_CDiDOQJwgWiiZ9Y2bZ2xk)
